Mar 6 |
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
|
Mar 1 |
Evogene files for $200M mixed shelf offering
|
Feb 28 |
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
|
Feb 26 |
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
|
Feb 21 |
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
|
Feb 20 |
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
|
Feb 6 |
Evogene and Verb Biotics collaborate to advance probiotic innovation
|
Feb 6 |
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
|
Jan 17 |
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
|